(±)-Dioxolane-T ((±)-1-[(2β,4β)-2-(hydroxymethyl)-4-dioxolanyl]thymine): A new 2′,3′-dideoxynucleoside prototype within vitro activity against HIV

This publication has 17 references indexed in Scilit:

• Aids Drugs—Coming But Not Here
  Science, 1989
• HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy
  Science, 1989
• Novel synthetic equivalents of differentially protected tartaric aldehydes. A simple route to useful c-4 chiral synthons.
  Tetrahedron Letters, 1988
• EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1988
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
  Proceedings of the National Academy of Sciences, 1986
• ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX
  The Lancet, 1986
• Saponin and sapogenol. XXIII. Degradation of methyl glucuronide and methyl galacturonide by lead tetraacetate oxidation followed by alkali treatment.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1978
• XXXVII.—Ethereal salts of glyceric acid, inactive and active
  Journal of the Chemical Society, Transactions, 1893